ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 215721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 215721; 2) Community: the network communities that were significantly associated with the response to NSC 215721; 3) Molecule: the relationships between components within communities and NSC 215721; 4) MDR: the compounds that were significantly associated with the NSC 215721.

NSC Compound Enrichment Correlation
NSC 632134 Null 0.0260391472224207 0.24202691
NSC 650365 Null 0.0260391472224207 0.12664159
NSC 698255 5'-Hydromethyl-2,5-bis-(2'selenyl)-N-methylpyrrol 0.0260391472224207 0.15020109
NSC 721319 ((4-((6-Iodo-2-(2-thienyl)quinazolin-4-yl) amino)phenyl)sulfonyl)-2,5-thiazolylamine 0.0260391472224207 0.18760501
NSC 725604 Null 0.0260391472224207 0.20216191
NSC 729520 Null 0.0260391472224207 0.035972054
NSC 736553 Ethyl 3-[4'-(thien-3''-yl)-1',2'-dihydronaphthalen-3'-yl]acrylate 0.0260391472224207 0.1385018
NSC 761130 (E)-6-chloro-3-((2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl)methylene)indolin-2-one 0.0260391472224207 0.12571897
NSC 762889 6-Chloro-5-[2-(piperazin-1-yl)ethyl]-1,3-dihydro-2H-indol-2-one 0.0260391472224207 0.26681103
NSC 105132 Deoxycamptothecin 0.0267520285931239 0.33069721
Total:76  Current:41    [First] [Prev] [Next] [Last]